Medical devices, healthcare technology and the business of care
510(k) clearance · K262904

INDIGO Aspiration System

Penumbra Inc. · Decision date Oct 15, 2026

MEDTECHLEDGER EXPLANATIONK262904

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for the INDIGO® Aspiration System, submitted by Penumbra, Inc. of Alameda, California, under 510(k) number K262904. The decision date is 10/15/2026, with the application received 08/18/2026. The device falls under regulation 870.5150, classification name Peripheral Mechanical Thrombectomy With Aspiration, product code QEW, in the Cardiovascular specialty and review panel. SESE denotes 510(k) clearance, not premarket approval.

The record identifies the application as a Traditional 510(k) and lists clinical trial NCT05003843. It states the submission was not reviewed by a third party, is not a combination product, and has no authorized Predetermined Change Control Plan. The page does not describe the specific device components, modifications or performance data supporting the equivalence finding, so the scope of what was cleared remains unknown from this source.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Oct 15, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262904
Regulatory pathway
510(k) premarket notification
Applicant
Penumbra Inc.
Product code
QEW
Decision code
SESE
Decision date
Oct 15, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Peripheral Mechanical Thrombectomy With Aspiration.

Applicant
Penumbra Inc.
Product code
QEW
FDA device class
2

FDA decision timeline

  1. K262904 received

    Application receipt date recorded by FDA.

  2. K262904 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QEW

Product / regulatory recordCompanyPathwayDecision dateSource
Inari Medical, Inc.510(k) clearanceSep 18, 2026FDA
Endovascular Engineering510(k) clearanceSep 3, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Penumbra Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Alameda, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records